STAT Plus: FDA is inspecting more foreign plants, but fewer domestic facilities
As concerns persist over the safety of medicines made overseas, the Food and Drug Administration recently touted data showing the number of facilities inspected in foreign countries had increased 20% over the most recent five-year period.
Specifically, the agency inspected 993 foreign plants in fiscal year 2014 compared with 1,245 in fiscal year 2018. At the same time, though, the FDA inspected fewer domestic facilities during that period — 1,869 versus 1,662, which amounts to a 12.5% drop.
Continue to STAT Plus to read the full story…
